| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oragenics Inc (OGEN) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 10 sells. OGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 250.0K | $153.3K | - | |
| Dir | 125.0K | $76.6K | - | |
| Dir | 125.0K | $76.6K | - | |
| Dir | 125.0K | $76.6K | - | |
| Dir | 125.0K | $76.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2022 | Telling Fred50 | Director | Buy | 10,084 | $0.29 | $2,884.02 | +1.0% | -10.9% | -84.7% | |
| May 24, 2022 | Telling Fred50 | Director | Buy | 82,173 | $0.29 | $23,779.98 | +4.5% | +29.5% | -82.0% | |
| May 20, 2022 | Telling Fred50 | Director | Buy | 65,718 | $0.28 | $18,637.62 | +7.7% | +33.9% | -82.4% | |
| May 19, 2022 | Telling Fred50 | Director | Buy | 72,109 | $0.28 | $19,939.53 | +4.6% | +36.0% | -82.2% | |
| Mar 31, 2022 | Telling Fred50 | Director | Buy | 183,838 | $0.36 | $66,053.42 | +14.0% | +3.3% | -84.1% | |
| Mar 29, 2022 | Sullivan Michael O'Keefe | Interim Peo, CFO | Buy | 20,000 | $0.35 | $6,922.00 | +140.3% | -9.6% | -85.9% | |
| Dec 31, 2021 | Koski Robert C71 | Director | Buy | 1,000,000 | $0.47 | $469,138.22 | +57.0% | -22.8% | -76.4% | |
| Jan 14, 2021 | Hernandez Joseph78 | 10% Owner | Sell | 4,200,000 | $0.74 | $3,117,289.08 | -20.8% | - | - | |
| Dec 22, 2020 | Koski Robert C71 | - | Sell | 310,000 | $0.43 | $132,432.00 | -28.5% | - | - | |
| Dec 2, 2020 | Hernandez Joseph78 | 10% Owner | Sell | 5,000,000 | $0.41 | $2,051,500.00 | -54.3% | - | - |